• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SUN1334H Inhibitor – SUN 1334h

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753982

SUN 1334H is a potent, orally active, highly selective antagonist of H1 receptor(Ki of 9.7nM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SUN 1334H (SUN1334H), Inhibitor
Full Product Name
SUN 1334H
Product Gene Name
Product Synonym Names
Soluble sulfamerazine
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
489.38
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C23H28Cl2F2N2O3
SMILES
O=C(O)COC/C=C/CN1CCN(C(C2=CC=C(F)C=C2)C3=CC=C(F)C=C3)CC1.[H]Cl.[H]Cl
CAS Number
607736-84-5
Target & IC50
H1 receptor(ki): ic50 9.7nM (ki)
In Vitro
In beagle dogs and ovalbumin-induced rhinitis in guinea pigs, SUN-1334H potently inhibits histamine-induced bronchospasm over 24 hours following oral administration and completely suppresses histamine-induced skin wheal [1]. SUN-1334H shows potent reduction of passive and active cutaneous anaphylactic reactions in skin allergy models. In central nervous system side effects models, SUN-1334H, desloratadine and fexofenadine are devoid of any significant effects[2].

Structure of SUN1334H, inhibitor

SUN1334H Inhibitor – Cat# MBS5753982

Product References and Citations for SUN1334H, inhibitor

Mandhane SN, et al. Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.
Mandhane SN, et al. Preclinical efficacy and safety pharmacology of SUN-1334H, a potent orally active antihistamine agent.
Mandhane SN, et al. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel
Mandhane SN, et al. Characterization of anti-inflammatory properties and evidence for no sedation liability for the novel

Other Notes

Small volumes of SUN1334H, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for SUN1334H purchase

MBS5753982 is an inhibitor targeting SUN1334H. Also known as SUN 1334H.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000